01 6BOEHRINGER INGELHEIM
01 611813275
01 6Blank
01 6Blank
01 62034-04-03
Patent Expiration Date : 2034-04-03
EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US Patent Number : 11813275
Drug Substance Claim :
Drug Product Claim :
Application Number : 206111
Patent Use Code : U-3759
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2034-04-03
Patent Expiration Date : 2034-04-03
US Patent Number : 11813275
Drug Substance Claim :
Drug Product Claim :
Application Number : 204629
Patent Use Code : U-3759
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2034-04-03
Patent Expiration Date : 2034-04-03
EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US Patent Number : 11813275
Drug Substance Claim :
Drug Product Claim :
Application Number : 206111
Patent Use Code : U-3759
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2034-04-03
Patent Expiration Date : 2034-04-03
EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US Patent Number : 11813275
Drug Substance Claim :
Drug Product Claim :
Application Number : 208658
Patent Use Code : U-3759
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2034-04-03
Patent Expiration Date : 2034-04-03
EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US Patent Number : 11813275
Drug Substance Claim :
Drug Product Claim :
Application Number : 208658
Patent Use Code : U-3759
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2034-04-03
Patent Expiration Date : 2034-04-03
US Patent Number : 11813275
Drug Substance Claim :
Drug Product Claim :
Application Number : 204629
Patent Use Code : U-3760
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2034-04-03
